Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -106,231 | -58,213 | -106,793 | -137,858 | -88,574 |
| Depreciation Amortization | -1,932 | -895 | -2,259 | -937 | -282 |
| Accounts receivable | 29,128 | 4,778 | -28,956 | -9,505 | -2,877 |
| Accounts payable and accrued liabilities | -3,292 | -1,897 | 4,812 | 755 | -659 |
| Other Working Capital | 31,755 | -16,616 | -34,375 | -12,794 | -16,536 |
| Other Operating Activity | -4,714 | 8,102 | 55,955 | 34,651 | 16,742 |
| Operating Cash Flow | $-55,286 | $-64,741 | $-111,616 | $-125,688 | $-92,186 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,202 | -446 | -4,315 | -2,874 | -2,546 |
| Purchase Of Investment | -292,332 | -135,001 | -460,301 | -379,728 | -141,361 |
| Sale Of Investment | 277,264 | 199,552 | 460,692 | 402,191 | 277,515 |
| Investing Cash Flow | $-16,270 | $64,105 | $-3,924 | $19,589 | $133,608 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,083 | -4,083 | -12,500 | -9,375 | -6,250 |
| Common Stock Issued | 96,644 | 117 | 12,285 | 12,285 | 12,285 |
| Other Financing Activity | 500 | 537 | 137,769 | 137,769 | 140,384 |
| Financing Cash Flow | $93,061 | $-3,429 | $137,554 | $140,679 | $146,419 |
| Beginning Cash Position | 70,140 | 70,140 | 48,126 | 48,126 | 48,126 |
| End Cash Position | 91,645 | 66,075 | 70,140 | 82,706 | 235,967 |
| Net Cash Flow | $21,505 | $-4,065 | $22,014 | $34,580 | $187,841 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,286 | -64,741 | -111,616 | -125,688 | -92,186 |
| Capital Expenditure | -1,202 | -446 | -4,315 | -2,874 | -2,546 |
| Free Cash Flow | -56,488 | -65,187 | -115,931 | -128,562 | -94,732 |